Related Experiment Video
Updated: May 2, 2026

09:04
A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
Published on: March 15, 2016
9.4K
VEGFR1-activity-independent metastasis formation
Michelle R Dawson1, Dan G Duda, Dai Fukumura
1Steele Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
Nature
|September 18, 2009
Summary
Blocking vascular endothelial growth factor receptor 1 (VEGFR1) did not prevent metastasis in a preclinical model. Alternative pathways likely mediate tissue priming for cancer spread.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Vascular Endothelial Growth Factor (VEGF) and Placental Growth Factor (PlGF) regulate tumor angiogenesis and are implicated in mobilizing bone marrow-derived cells (BMDCs).
- Previous studies suggested that BMDCs form 'metastatic niches' in lungs, facilitated by VEGFR1, prior to cancer cell arrival.
- Pharmacological inhibition of VEGFR1 was shown to prevent BMDC infiltration and metastatic niche formation in preclinical models.
Discussion:
- This study investigated the role of VEGFR1 in spontaneous metastasis using a clinically relevant preclinical model.
- The findings challenge the established role of VEGFR1 in mediating BMDC recruitment and 'metastatic niche' formation.
- Blockade of VEGFR1 activity did not impact the rate of spontaneous metastasis formation.
Key Insights:
- VEGFR1 blockade is ineffective in preventing spontaneous metastasis in a widely used preclinical model.
- The previously proposed mechanism involving VEGFR1 in 'metastatic niche' formation appears not to be universally applicable.
- Tumor metastasis and the formation of pre-metastatic niches may involve alternative signaling pathways.
Outlook:
- Further research is needed to identify alternative pathways that mediate tissue priming for metastasis.
- Understanding these alternative pathways could lead to novel therapeutic strategies targeting cancer metastasis.
- Investigating other growth factor receptors and their roles in BMDC mobilization and extravasation is warranted.
Related Concept Videos
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Mechanism of Angiogenesis
6.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Receptor Tyrosine Kinases
15.5K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.5K
MAPK Signaling Cascades
7.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K

